Amygdalar Asymmetry on Imaging: Clinical Significance
Amygdalar asymmetry on imaging is generally not clinically significant in most acute neurological presentations, as current ACR guidelines do not identify it as a relevant finding requiring action in altered mental status, delirium, psychosis, or dementia evaluations.
Context from Neuroimaging Guidelines
The ACR Appropriateness Criteria for altered mental status, delirium, and psychosis 1 focus on identifying acute pathology such as hemorrhage, stroke, mass lesions, and infection. Amygdalar asymmetry is not mentioned as a clinically actionable finding in these guidelines, which prioritize detection of treatment-altering abnormalities that affect immediate management.
Similarly, in dementia imaging 2, the focus is on regional atrophy patterns (particularly hippocampal and entorhinal cortex volume loss), amyloid deposition, and metabolic changes—not on amygdalar asymmetry as a diagnostic criterion.
When Amygdalar Asymmetry May Have Significance
Temporal Lobe Epilepsy (TLE)
The most clinically relevant context for amygdalar asymmetry is in temporal lobe epilepsy without hippocampal sclerosis 3:
- Asymmetric amygdalar enlargement has robust lateralizing value in TLE
- Positive asymmetry index (rightward enlargement) associates with right TLE or bitemporal epilepsy
- Negative asymmetry index (leftward enlargement) associates with left TLE
- Mean volume differences of 200-226 mm³ compared to controls
- Greater asymmetry correlates with higher amygdalar involvement in seizures
Clinical application: In patients with seizures undergoing epilepsy workup, amygdalar asymmetry can help lateralize the seizure focus, particularly when hippocampal sclerosis is absent.
Alzheimer's Disease and Dementia
Research shows amygdalar asymmetry increases with disease severity in AD 4, 5:
- Rightward lateralization of amygdalar volume occurs in AD
- Shape asymmetries (not just volume) predict progression from MCI to dementia
- Asymmetry correlates with disease severity and functional impairment
However, this remains a research finding without established clinical thresholds or treatment implications. Current dementia guidelines 2 do not recommend using amygdalar asymmetry for diagnosis or management decisions.
Atypical Parkinsonian Syndromes
In corticobasal syndrome (CBS), perfusion asymmetry of the amygdala may help differentiate from progressive supranuclear palsy 6, but this is a specialized research application not reflected in standard imaging guidelines.
Practical Interpretation Algorithm
For routine clinical imaging:
Acute presentations (AMS, delirium, psychosis): Ignore amygdalar asymmetry unless accompanied by mass effect, edema, or enhancement suggesting tumor, infection, or acute pathology 1
Seizure evaluation: Document amygdalar asymmetry and correlate with seizure semiology and EEG findings. Consider as supportive evidence for lateralization in epilepsy surgery candidates 3
Dementia workup: Focus on hippocampal atrophy patterns, not amygdalar asymmetry, as per current guidelines 2
Incidental finding: If amygdalar asymmetry is noted without clinical context, no specific follow-up is indicated unless there are concerning features (mass, enhancement, edema)
Common Pitfalls
- Physiological asymmetry exists: Normal humans have right-left amygdalar volume differences 7. Not all asymmetry is pathological.
- Age-related changes: Asymmetry patterns may change with normal aging 8
- Measurement variability: Small structures like the amygdala have higher measurement variability (~5%) on MRI 8, making subtle asymmetries unreliable
Bottom Line
Amygdalar asymmetry should only be considered clinically significant in the specific context of temporal lobe epilepsy lateralization 3. In all other acute neurological presentations covered by current guidelines, it does not alter management and should not trigger additional workup or concern unless accompanied by other pathological features.